Sirolimus as Primary Therapy for the Treatment of Chronic Graft Versus Host Disease

NCT00186667 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Graft vs Host Disease
Blood and Marrow Transplant (BMT)

Interventions

PROCEDURE: high dose chemotherapy and autologous hematopoietic cell transplant

Sponsor

Stanford University